Related Experiment Video
Updated: Jul 18, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Feature-similarity protein classifier as a ligand engineering tool.
Sridhar Maddipati1, Ariel Fernández
1School of Chemical Engineering, Purdue University, West Lafayette, IN 47906, USA.
Sticky packing defects in protein kinases offer a novel target for designing selective drugs. By clustering kinases based on packing differences, researchers can identify unique binding sites, enhancing drug specificity and reducing cross-reactivity in signaling pathway therapies.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- Kinase inhibitors are crucial for blocking signaling pathways in drug therapy.
- Protein structure conservation across kinase homologs often results in undesirable cross-reactivity.
- Ligand-anchoring sites, such as sticky packing defects, are typically not conserved and can enhance drug selectivity.
Purpose of the Study:
- To introduce a novel strategy for designing selective kinase inhibitors.
- To partition the kinome based on packing differences for improved drug targeting.
- To investigate the relationship between packing sensitivity and drug promiscuity.
Main Methods:
- Hierarchical clustering of protein data bank (PDB)-reported kinases based on packing differences.
- Correlation analysis between kinome partitioning and pharmacological profiling.
- Assessment of drug sensitivity to packing variations.
Main Results:
- Kinome partitioning based on packing defects shows high correlation with pharmacological proximity.
- A variable packing sensitivity was observed for different drugs.
- Highly promiscuous ligands exhibited the lowest sensitivity to packing differences.
Conclusions:
- Sticky packing defects represent promising, non-conserved targets for enhancing kinase inhibitor selectivity.
- The developed classifier provides a strategic framework for designing more specific kinase-targeted therapies.
- Understanding packing variations is key to overcoming cross-reactivity issues in kinase drug discovery.
More Related Videos
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
06:50Computational Prediction of Amino Acid Preferences of Potentially Multispecific Peptide-Binding Domains Involved in Protein-Protein Interactions
Published on: January 26, 2024
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-protein Interfaces
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage
Ligand Binding and Linkage
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...